 |
2-(7-ethoxy-4-(3-fluorophenyl)-1-oxophthalazin-2(1H)-yl)-N-methyl-N-(2-methylbenzo[d]oxazol-6-yl)acetamide |
|---|---|
| Trade Name | |
| Orphan Indication | Cystic fibrosis |
| EU Market Approval | EU |
| EU Designation Date | 2015-05-21 00:00:00 |
| Sponsor | Clinical Network Services (UK) Ltd |
Related Access Program